A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.

[1]  K. Krogfelt,et al.  Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. , 2010, Vaccine.

[2]  L. Schuerman,et al.  Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A? , 2010, BMC pediatrics.

[3]  K. O'Brien,et al.  Nasopharyngeal Carriage of Streptococcus pneumoniae in Navajo and White Mountain Apache Children Before the Introduction of Pneumococcal Conjugate Vaccine , 2009, The Pediatric infectious disease journal.

[4]  M. Lipsitch,et al.  Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children , 2009, Pediatrics.

[5]  D. Greenberg,et al.  Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. , 2009, The Journal of infectious diseases.

[6]  J. Treanor,et al.  Differential effects of pneumococcal vaccines against serotypes 6A and 6C. , 2008, The Journal of infectious diseases.

[7]  H. Slotved,et al.  An easy method for detection of nasopharyngeal carriage of multiple Streptococcus pneumoniae serotypes. , 2008, Journal of microbiological methods.

[8]  M. Linden.  Surveillance of IPD in Children in Germany 2004 - 2008, First Results of the German National Immunization Program for PCV7 , 2008 .

[9]  K. O'Brien,et al.  Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  K. O'Brien,et al.  Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  D. Caugant,et al.  Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. , 2008, Vaccine.

[12]  P. Nilsson,et al.  An individual-based network model to evaluate interventions for controlling pneumococcal transmission , 2008, BMC infectious diseases.

[13]  G. Syrogiannopoulos,et al.  Impact of Heptavalent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of Penicillin-Resistant Streptococcus pneumoniae Among Day-Care Center Attendees in Central Greece , 2008, The Pediatric infectious disease journal.

[14]  D. Greenberg,et al.  Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? , 2008, The Journal of infectious diseases.

[15]  A. Schuchat,et al.  Impact of Conjugate Vaccine on Transmission of Antimicrobial-Resistant Streptococcus pneumoniae Among Alaskan Children , 2008, The Pediatric infectious disease journal.

[16]  W. Schaffner,et al.  Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. , 2008, The Journal of infectious diseases.

[17]  E. Bingen,et al.  Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[18]  S. Kim,et al.  Streptococcus pneumoniae Serotype 19A in Children, South Korea , 2008, Emerging infectious diseases.

[19]  W. Schaffner,et al.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. , 2007, The Journal of infectious diseases.

[20]  M. Pichichero,et al.  Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. , 2007, JAMA.

[21]  K. O'Brien,et al.  Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. , 2007, The Journal of infectious diseases.

[22]  E. Lewis,et al.  Surveillance for Invasive Pneumococcal Disease During 2000–2005 in a Population of Children Who Received 7-Valent Pneumococcal Conjugate Vaccine , 2007, The Pediatric infectious disease journal.

[23]  A. Melegaro,et al.  Pneumococcal carriage in United Kingdom families: estimating serotype-specific transmission parameters from longitudinal data. , 2007, American journal of epidemiology.

[24]  D. Rasko,et al.  Impact of the Pneumococcal Conjugate Vaccine on Serotype Distribution and Antimicrobial Resistance of Invasive Streptococcus pneumoniae Isolates in Dallas, TX, Children From 1999 Through 2005 , 2007, The Pediatric infectious disease journal.

[25]  Susan S. Huang,et al.  Emergence of 19A as Virulent and Multidrug Resistant Pneumococcus in Massachusetts Following Universal Immunization of Infants With Pneumococcal Conjugate Vaccine , 2007, The Pediatric infectious disease journal.

[26]  L. Hammitt,et al.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. , 2007, JAMA.

[27]  R. Cohen,et al.  Impact of Pneumococcal Conjugate Vaccine and of Reduction of Antibiotic Use on Nasopharyngeal Carriage of Nonsusceptible Pneumococci in Children With Acute Otitis Media , 2006, The Pediatric infectious disease journal.

[28]  W. Schaffner,et al.  Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study , 2006, The Lancet.

[29]  K. Auranen,et al.  Nasopharyngeal colonization: a target for pneumococcal vaccination , 2006, Expert review of vaccines.

[30]  D. Greenberg,et al.  Will Reduction of Antibiotic Use Reduce Antibiotic Resistance?: The Pneumococcus Paradigm , 2006, The Pediatric infectious disease journal.

[31]  T. Peto,et al.  Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. , 2006, The Journal of infectious diseases.

[32]  K. O'Brien,et al.  Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  M. Lipsitch,et al.  Incremental increase in fitness cost with increased beta -lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model. , 2006, The Journal of infectious diseases.

[34]  W. Schaffner,et al.  Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. , 2006, The New England journal of medicine.

[35]  D. Farrell,et al.  Heterogeneous Macrolide Resistance and Gene Conversion in the Pneumococcus , 2006, Antimicrobial Agents and Chemotherapy.

[36]  C. Whitney,et al.  Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. , 2005, The Journal of infectious diseases.

[37]  D Guillemot,et al.  Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection , 2005, Epidemiology and Infection.

[38]  A. Schuchat,et al.  Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. , 2004, The Journal of infectious diseases.

[39]  S. Pelton,et al.  Seven Valent Pneumococcal Conjugate Vaccine Immunization in Two Boston Communities: Changes in Serotypes and Antimicrobial Susceptibility Among Streptococcus pneumoniae Isolates , 2004, The Pediatric infectious disease journal.

[40]  Richard Platt,et al.  Post-PCV7 Changes in Colonizing Pneumococcal Serotypes in 16 Massachusetts Communities, 2001 and 2004 , 2004, Pediatrics.

[41]  P. Böelle,et al.  Short- and Long-Term Effects of Pneumococcal Conjugate Vaccination of Children on Penicillin Resistance , 2004, Antimicrobial Agents and Chemotherapy.

[42]  R. Platt,et al.  Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. , 2003, Pediatrics.

[43]  B. Spratt,et al.  Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. , 2003, The Journal of infectious diseases.

[44]  A. Schuchat,et al.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The New England journal of medicine.

[45]  K. O'Brien,et al.  Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae , 2003, The Pediatric infectious disease journal.

[46]  G. Mccracken,et al.  Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  R. Dagan,et al.  Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. , 2002, The Journal of infectious diseases.

[48]  S. Lockhart,et al.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media. , 2001, The New England journal of medicine.

[49]  G. Mccracken,et al.  Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  R. Huebner,et al.  Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. , 1999, The Journal of infectious diseases.

[51]  L. White,et al.  Cross immunity and vaccination against multiple microparasite strains. , 1998, IMA journal of mathematics applied in medicine and biology.

[52]  M. Lipsitch.  Vaccination against colonizing bacteria with multiple serotypes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Hillman,et al.  Infections of the Central Nervous System , 1992, Neurology.

[54]  B. Schwartz,et al.  Uptake of pneumococcal conjugate vaccine among children in the 1998-2002 United States birth cohorts. , 2008, American journal of preventive medicine.

[55]  S. Madhi,et al.  Meta-Analysis of the Efficacy of Conjugate Vaccines against Invasive Pneumococcal Disease , 2008 .

[56]  Carlos Castillo-Chavez,et al.  Estimation of invasive pneumococcal disease dynamics parameters and the impact of conjugate vaccination in Australia. , 2008, Mathematical biosciences and engineering : MBE.

[57]  G. Siber,et al.  Pneumococcal vaccines: the impact of conjugate vaccine. , 2008 .

[58]  A. Melegaro.  Epidemiology, mathematical modelling and economics of Streptococcus pneumoniae : assessing the potential impact of vaccination , 2005 .

[59]  L. Harrison,et al.  Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.